(Q26823015)

main subject

neoplastic stem cells

1 reference

Selcuk Colak

1

1 reference

Jan P. Medema

series ordinal

2

1 reference

language of work or name

1 reference

November 2014

1 reference

1 reference

281

1 reference

issue

21

1 reference

page(s)

4779-91

1 reference

Cancer drug resistance: an evolving paradigm

cites work

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Multidrug resistance in cancer: role of ATP-dependent transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Efficient tumour formation by single human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Tumour heterogeneity and cancer cell plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Cancer stem cells: impact, heterogeneity, and uncertainty

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Epithelial stem cells: turning over new leaves

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Microenvironmental regulation of stem cells in intestinal homeostasis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

A role for Wnt signalling in self-renewal of haematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Wnt proteins are self-renewal factors for mammary stem cells and promote their long-term expansion in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Links between signal transduction, transcription and adhesion in epithelial bud development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Identification of selective inhibitors of cancer stem cells by high-throughput screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Wnt activity defines colon cancer stem cells and is regulated by the microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Regulation of stem cell self-renewal and differentiation by Wnt and Notch are conserved throughout the adenoma-carcinoma sequence in the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Increased DNA single-strand break joining activity in UV-irradiated CD34+ versus CD34- bone marrow cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Identification of stem cells in small intestine and colon by marker gene Lgr5

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Lgr proteins in epithelial stem cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Lgr5 marks cycling, yet long-lived, hair follicle stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

LGR5 positivity defines stem-like cells in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Retinoid signaling regulates breast cancer stem cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

The role of human aldehyde dehydrogenase in normal and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Decreased mitochondrial priming determines chemoresistance of colon cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Chemotherapy resistance of glioblastoma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Exploring the role of cancer stem cells in radioresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Association of reactive oxygen species levels and radioresistance in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

A restricted cell population propagates glioblastoma growth after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

ABCB5 identifies a therapy-refractory tumor cell population in colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

let-7 regulates self renewal and tumorigenicity of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Accumulation of CD133-positive glioma cells after high-dose irradiation by Gamma Knife surgery plus external beam radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Mitochondria and cell death: outer membrane permeabilization and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

The anti-apoptotic genes Bcl-X(L) and Bcl-2 are over-expressed and contribute to chemoresistance of non-proliferating leukaemic CD34+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Comparative proteomics of colon cancer stem cells and differentiated tumor cells identifies BIRC6 as a potential therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

BH3 profiling--measuring integrated function of the mitochondrial apoptotic pathway to predict cell fate decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Expression of multidrug resistance genes in normal and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Identification of cells initiating human melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Depletion of Chk1 leads to premature activation of Cdc2-cyclin B and mitotic catastrophe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Targeting colorectal cancer stem cells with inducible caspase-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Targeted inhibition of CD133+ cells in oral cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Specific elimination of CD133+ tumor cells with targeted oncolytic measles virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Photochemical internalization (PCI) of immunotoxins targeting CD133 is specific and highly potent at femtomolar levels in cells with cancer stem cell properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Genetic and pharmacologic inhibition of β-catenin targets imatinib-resistant leukemia stem cells in CML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

A perivascular niche for brain tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Targeting of CD44 eradicates human acute myeloid leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

ER stress causes rapid loss of intestinal epithelial stemness through activation of the unfolded protein response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

7 January 2021

Cancer stem cells: the challenges ahead

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

7 January 2021

Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

7 January 2021

Preferential expression of a high number of ATP binding cassette transporters in both normal and leukemic CD34+CD38- cells

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

7 January 2021

Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

7 January 2021

Tumor growth need not be driven by rare cancer stem cells

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13023

7 January 2021

Identifiers

DOI

10.1111/FEBS.13023

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

25158828

1 reference

Consolidated OpenCitations Corpus – April 2017